Welcome to our dedicated page for Nano-X Imaging Ltd. news (Ticker: $NNOX), a resource for investors and traders seeking the latest updates and insights on Nano-X Imaging Ltd. stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nano-X Imaging Ltd.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nano-X Imaging Ltd.'s position in the market.
Nanox Imaging announced its Q1 2024 financial results, reporting revenues of $2.6 million, up from $2.4 million in Q1 2023. However, the net loss increased to $12.2 million from $11.8 million in the previous year. The company secured agreements with Dandelion Health and Covera Health for its AI solutions and demonstrated its Nanox.ARC scanning technology in New Jersey. Nanox also entered a partnership with Swissray to improve customer support. Despite a decrease in research and administrative expenses, gross loss increased significantly. Cash reserves dropped to $73.3 million from $82.8 million at the end of 2023.
Nanox Imaging, a medical imaging technology company, will announce its financial results for Q1 2024 on May 28, 2024. The report, covering the period ending March 31, 2024, will be released before the market opens. CEO Erez Meltzer and CFO Ran Daniel will host a conference call at 8:30 a.m. ET to review the results and provide a business update. Interested parties can register for the call or access the live webcast via links available on Nanox's Investor Relations section.
NANO-X IMAGING , the innovative medical imaging technology company, announced that its teleradiology subsidiary, USARAD Holdings, Inc., has been awarded The Joint Commission's Gold Seal of Approval for Ambulatory Health Care Accreditation for the sixth time. This accreditation reflects the organization's commitment to safe and quality patient care.
Nanox, a medical imaging technology company, is set to participate in three investor conferences in May 2024. The conferences include EF Hutton 2024 Annual Global Conference, AGP 2024 Healthcare Conference, and Benchmark 2024 Healthcare House Call Virtual Conference.